PSEUDOGOUT ASSOCIATED WITH THE USE OF CYCLICAL ETIDRONATE THERAPY

被引：15

作者：

GALLACHER, SJ ^{[1
]}

BOYLE, IT ^{[1
]}

CAPELL, HA ^{[1
]}

机构：

[1] UNIV GLASGOW,GLASGOW ROYAL INFIRM,CTR RHEUMAT DIS,GLASGOW G31 2ER,SCOTLAND

来源：

SCOTTISH MEDICAL JOURNAL | 1991年 / 36卷 / 02期

关键词：

OSTEOPOROSIS; DIPHOSPHONATES; PSEUDOGOUT;

D O I：

10.1177/003693309103600207

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recently the use of etidronate in a cyclical fashion has been shown to be of value in the treatment of osteoporosis. Like all bisphosphonates etidronate is structurally similar to pyrophosphate, further it is also known to interfere with phosphate handling by the kidney resulting in elevated plasma phosphate levels. This report describes the case of a patient with established osteoporosis who developed pseudogout associated with cyclical etidronate use. The possible mechanism responsible for this is discussed.

引用

页码：49 / 49

页数：1

共 8 条

[1] DIPHOSPHONATES INHIBIT HYDROXYAPATITE DISSOLUTION IN VITRO AND BONE RESORPTION IN TISSUE CULTURE AND IN VIVO [J].

FLEISCH, H ;

RUSSELL, RGG ;

FRANCIS, MD .

SCIENCE, 1969, 165 (3899) :1262-&

[2]

FLEISCH H, 1985, BONE RESORPTION META, P33

[3] BINDING OF PYROPHOSPHATE AND TWO DIPHOSPHONATES BY HYDROXYAPATITE CRYSTALS [J].

JUNG, A ;

BISAZ, S ;

FLEISCH, H .

CALCIFIED TISSUE RESEARCH, 1973, 11 (04) :269-280

[4]

LICATA A, 1989, J BONE MINRES S1, V4, pS378

[5]

RALSTON SH, 1985, LANCET, V2, P907

[6]

REID IR, 1988, LANCET, V1, P143

[7]

SMITH R, 1973, Q J MED, V42, P235

[8] CHANGES IN RENAL AND EXTRA-RENAL HANDLING OF PHOSPHATE INDUCED BY DISODIUM ETIDRONATE (EHDP) IN MAN [J].

WALTON, RJ ;

RUSSELL, RGG ;

SMITH, R .

CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 49 (01) :45-56

← 1 →